BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34743704)

  • 1. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.
    Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
    Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
    Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
    Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy.
    Leali M; Aimo A; Ricci G; Torri F; Todiere G; Vergaro G; Grigoratos C; Giannoni A; Aquaro GD; Siciliano G; Emdin M; Passino C; Barison A
    J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):340-347. PubMed ID: 37129928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
    Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.
    Starc JJ; Moore RA; Rattan MS; Villa CR; Gao Z; Mazur W; Jefferies JL; Taylor MD
    Pediatr Cardiol; 2017 Oct; 38(7):1485-1492. PubMed ID: 28762167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
    Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study.
    Smith GC; Kinali M; Prasad SK; Bonne G; Muntoni F; Pennell DJ; Nihoyannopoulos P
    J Cardiovasc Magn Reson; 2006; 8(5):723-30. PubMed ID: 16891232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy.
    Kashyap N; Nikhanj A; Labib D; Prosia E; Rivest S; Flewitt J; Pfeffer G; Bakal JA; Siddiqi ZA; Coulden RA; Thompson R; White JA; Oudit GY
    J Am Heart Assoc; 2023 Nov; 12(21):e030229. PubMed ID: 37929714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.
    Rosales XQ; Moser SJ; Tran T; McCarthy B; Dunn N; Habib P; Simonetti OP; Mendell JR; Raman SV
    J Cardiovasc Magn Reson; 2011 Aug; 13(1):39. PubMed ID: 21816046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
    Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
    Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
    Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
    J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
    Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.